Certolizumab Pegol Effective for Axial SpondyloarthritisCertolizumab Pegol Effective for Axial Spondyloarthritis

Certolizumab pegol safely reduced signs and symptoms of axial spondyloarthritis (SpA), including ankylosing spondylitis (AS), in the RAPID-axSpA trial. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news